Quality of Nursing Care During The Covid-19 Pandemic

May 2, 2023 updated by: Mukaddes Demir Acar, Tokat Gaziosmanpasa University

Quality of Nursing Care During The Covid-19 Pandemic From The Perspective Of Hospitalized Children: A Cross-Sectional Study

Enabling school-age children to evaluate the care they receive provides feedback on the quality of care by determining children's satisfaction with care, and gives important feedback on the quantity and quality of care. Evaluation of nursing care, emotions and behaviors from the perspective of children during the Covid-19 pandemic process will guide the improvement of the quality of care. As a result of the literature review on this subject, no research has been found, and it is thought that this research will contribute to the field. This research was conducted to evaluate nursing care and emotions from the perspective of hospitalized children during the Covid-19 pandemic process.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

128

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Eyalet/Yerleşke
      • Tokat, Eyalet/Yerleşke, Turkey, 60200
        • Tokat Gaziosmanpasa University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

This cross-sectional descriptive study was conducted in a hospital in the Black Sea Region of XXX between February and June 2021

Description

Inclusion Criteria:

  • The study included volunteer children who were hospitalized for at least 3 days in the - -- -pediatric clinic,
  • whose native language was Turkish,
  • between the ages of 8-13,
  • who did not have any visual, auditory or mental problems, and whose parents gave consent for the study.

Exclusion Criteria:

  • who fall outside the inclusion criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
study group
8-13 age group (N=128).
This research was conducted to evaluate nursing care from the perspective of hospitalized children during the Covid-19 pandemic process and to determine their feelings during this process.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Scale Evaluation Quality of Care From Children's Point of View
Time Frame: 4 month
The Scale Evaluation Quality of Care From Children's Point of View is a 5-point Likert-type scale (never = 1, rarely agree = 2, sometimes agree= 3, often agree = 4, always agree=5) involving 15 items, which was developed by Yilmaz and Ak (2018). The minimum score that can be obtained from the scale is 15 and the maximum score is 75.
4 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Mukaddes Demir Acar, Tokat Gaziosmanpasa University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2021

Primary Completion (Actual)

March 1, 2021

Study Completion (Actual)

June 30, 2021

Study Registration Dates

First Submitted

April 29, 2023

First Submitted That Met QC Criteria

May 2, 2023

First Posted (Actual)

May 3, 2023

Study Record Updates

Last Update Posted (Actual)

May 3, 2023

Last Update Submitted That Met QC Criteria

May 2, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Supporting Information Type

  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hospitalism

Clinical Trials on descriptive

3
Subscribe